Loading data for CANC — first visit, this takes a few seconds.
Tema Oncology ETF (CANC)
NasdaqGM: CANC
· Real-Time Price · USD
43.82
+1.07 (2.50%)
At close: Aug 18, 2026, 8:00 PM
Tema Oncology ETF (CANC) ETF Price, Holdings & Analysis
2.50% (1D)
No data available
| Bid | 41.61 |
| Market Cap | n/a |
| AUM | 193.31M |
| NAV | 43.15 |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 27.56 |
| Shares Out | n/a |
| Inception Date | Aug 14, 2023 |
| Ask | 42.11 |
| Volume | 10,875 |
| Avg. Volume (20D) | 32,409 |
| Open | 42.58 |
| Previous Close | 42.75 |
| Day's Range | 41.86 - 42.66 |
| 52-Week Range | 26.24 - 43.51 |
| Holdings | n/a |
| Expense Ratio | 0.75% |
About CANC
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Asset Class Equity
Ticker Symbol CANC
Inception Date Aug 14, 2023
Provider Tema Etfs
Website Fund Home Page
Exchange NasdaqGM
Top 10 Holdings 42.56% of assets
| Name | Symbol | Weight |
|---|---|---|
| Revolution Medicines... | RVMD | 6.14% |
| Cogent Biosciences I... | COGT | 5.31% |
| Eli Lilly And Co | LLY | 5.22% |
| Roche Holding Ag Adr | RHHBY | 4.65% |
| Novartis Ag Register... | NOVN.SW | 4.16% |
| Bristol-myers Squibb... | BMY | 3.73% |
| Abbvie Inc | ABBV | 3.72% |
| Merck & Co Inc | MRK | 3.65% |
| Johnson & Johnson | JNJ | 3.13% |
| Immunome Inc Ordinar... | IMNM | 2.85% |
Dividends Dividend Yield 0.05%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 10, 2025 | $0.0200 | n/a |
| Dec 11, 2024 | $0.7280 | n/a |
| Dec 13, 2023 | $0.1490 | n/a |
